Litigation Details for Sanofi-Aventis U.S. LLC v. Alvogen Pine Brook LLC (D. Del. 2016)
✉ Email this page to a colleague
Sanofi-Aventis U.S. LLC v. Alvogen Pine Brook LLC (D. Del. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-12-22 |
| Court | District Court, D. Delaware | Date Terminated | 2018-01-02 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Parties | SANOFI-AVENTIS U.S. LLC | ||
| Patents | 6,794,410; 9,186,346 | ||
| Attorneys | Paul H. Berghoff | ||
| Firms | Proctor Heyman Enerio LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Sanofi-Aventis U.S. LLC v. Alvogen Pine Brook LLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Sanofi-Aventis U.S. LLC v. Alvogen Pine Brook LLC (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-12-21 | 1 | infringement of United States Patent Nos. 6,794,410 (“the ‘410 patent,” a true and accurate copy of …United States Patent and Trademark Office granted reexamination certificate C1 6,794,410 for the ‘410 … INFRINGEMENT OF U.S. PATENT NO. 6,794,410 46. Plaintiffs repeat and reallege…INFRINGEMENT OF U.S. PATENT NO. 6,794,410 51. Plaintiffs repeat and reallege…the ‘410 patent. The ‘410 patent will expire on April 15, 2022. 17. The ‘346 patent, titled | External link to document | |
| 2016-12-21 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,794,410 C1; US 9,186,346 …2016 2 January 2018 1:16-cv-01300 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
